Company

Sanaregen™ Vision Therapeutics

Biotechnology Research 1831 12th Ave S 2 employees

Employees: 2
Contacts: 1
Emails: 1
Phones: 1

www.sanaregenvision.com LinkedIn

Sanaregen™ Vision Therapeutics Overview

Headquarters: 1831 12th Ave S
Website: www.sanaregenvision.com
Industry: Biotechnology Research
Employees: 2
Founded: 2024
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Regenerative Medicine Macular Degeneration Degenerative Retinal Disease Retinopathies Stem Cells Vision Restoration Geographic Atrophy

About Sanaregen™ Vision Therapeutics

Sanaregen Vision Therapeutics, Inc. is a clinical-stage biopharmaceutical research and development company that is developing one of the first regenerative medicine treatments designed to effectively treat degenerative retinal diseases. With creative trial design, iterative development, and platform technology with multimodal capabilities, we create potential for accelerated approvals and first-to-market positioning.

Sanaregen™ Vision Therapeutics Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage
Phone contacts: 1; 50.0% coverage

Sanaregen™ Vision Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Anthony Oliva	Regenerative Medicine; Retina Disorders; Geroscience; Aging Research; Neuroscience; Clinical Trials; Scientific Affairs; Regulatory Affairs.	Miami, Florida, United States	Email Phone
Doug Oliver, Msw	Founder of Sanaregen Vision Therapeutics. Award-winning Patient Visionary Who Got Up from the "children's Table" and Moved Instead to Sit at the Head		View